SCHEMBL4177396

SCHEMBL4177396

COC(=O)[C@H](Cc1ccccc1)NC(=O)c1ccc(C)cc1C

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 2/20 0.58
L3MBTL1 Q9Y468 1/20 0.58
ALDH1A1 P00352 4/20 0.57
TACR3 P29371 1/20 0.57
KDM4E B2RXH2 1/20 0.57
PKM P14618 1/20 0.57
RAB9A P51151 2/20 0.57
GAA P10253 1/20 0.57
THRB P10828 1/20 0.53
CYP2C9 P11712 1/20 0.53
CYP2C19 P33261 1/20 0.53
HSD17B10 Q99714 1/20 0.53
LMNA P02545 1/20 0.53
GLA P06280 1/20 0.53
POLB P06746 2/20 0.52
TAS1R3 Q7RTX0 1/20 0.52
TAS1R1 Q7RTX1 1/20 0.52
TAS1R2 Q8TE23 1/20 0.52
NPC1 O15118 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4166667 0.90 POLB (0.59) ATML3MBTL1ALDH1A1TACR3KDM4E
SCHEMBL4166643 0.88 L3MBTL1 (0.63) L3MBTL1ALDH1A1RAB9APOLBTAS1R3
SCHEMBL28595293 0.87 ATM (0.59) ATML3MBTL1ALDH1A1TACR3KDM4E
SCHEMBL4172927 0.87 ATM (0.59) ATML3MBTL1ALDH1A1TACR3KDM4E
SCHEMBL13927753 0.85 L3MBTL1 (0.61) ATML3MBTL1ALDH1A1TACR3KDM4E
SCHEMBL26820570 0.84 GAA (0.73) ATML3MBTL1ALDH1A1RAB9AGAA
SCHEMBL4175147 0.84 GAA (0.73) ATML3MBTL1ALDH1A1RAB9AGAA
SCHEMBL22647177 0.82 ALDH1A1 (0.57) ATML3MBTL1ALDH1A1TACR3KDM4E
SCHEMBL4180329 0.81 ALDH1A1 (0.67) ATML3MBTL1ALDH1A1RAB9AGAA
SCHEMBL31389127 0.81 GAA (0.65) ATML3MBTL1ALDH1A1TACR3KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090047379-A1 Benzamide Compounds Useful as High Potency Sweet Taste Enhancers DEWIS MARK L 2009-02-19 US disclosed
US-20090047379-A1 Benzamide Compounds Useful as High Potency Sweet Taste Enhancers DEWIS MARK L 2009-02-19 US disclosed
US-20090047379-A1 Benzamide Compounds Useful as High Potency Sweet Taste Enhancers DEWIS MARK L 2009-02-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090047379-A1 Benzamide Compounds Useful as High Potency Sweet Taste Enhancers TAS2R10, TAS2R50, TAS2R8 ATM 1831/4885L3MBTL1 4231/4885ALDH1A1 818/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.